Elevation Tax Provision from 2010 to 2025

ELEV Stock  USD 0.67  0  0.30%   
Elevation Oncology Tax Provision yearly trend continues to be fairly stable with very little volatility. Tax Provision is likely to outpace its year average in 2025. Tax Provision is the amount set aside by Elevation Oncology to cover any estimated taxes for the current period. It reflects Elevation Oncology's expected tax liabilities. View All Fundamentals
 
Tax Provision  
First Reported
2010-12-31
Previous Quarter
52.9 K
Current Value
55.5 K
Quarterly Volatility
21 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 5 M or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.32. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.
  
Check out the analysis of Elevation Oncology Correlation against competitors.
For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.

Latest Elevation Oncology's Tax Provision Growth Pattern

Below is the plot of the Tax Provision of Elevation Oncology over the last few years. It is the amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities. Elevation Oncology's Tax Provision historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.
Tax Provision10 Years Trend
Slightly volatile
   Tax Provision   
       Timeline  

Elevation Tax Provision Regression Statistics

Arithmetic Mean11,215
Geometric Mean0.00
Coefficient Of Variation187.20
Mean Deviation16,823
Median0.00
Standard Deviation20,995
Sample Variance440.8M
Range55.5K
R-Value0.75
Mean Square Error206M
R-Squared0.56
Significance0.0008
Slope3,312
Total Sum of Squares6.6B

Elevation Tax Provision History

202555.5 K
202452.9 K
202346 K
202225 K

About Elevation Oncology Financial Statements

Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Tax Provision, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tax Provision52.9 K55.5 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.